<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Urologiia</journal-id><journal-title-group><journal-title xml:lang="en">Urologiia</journal-title><trans-title-group xml:lang="ru"><trans-title>Урология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1728-2985</issn><issn publication-format="electronic">2414-9020</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">281149</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Experimental validation of ND:YAG laser coagulation of the bladder tissue</article-title><trans-title-group xml:lang="ru"><trans-title>Экспериментальное обоснование использования ND:YAG-лазерной коагуляции ткани мочевого пузыря</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rasshupkina</surname><given-names>E. V</given-names></name><name xml:lang="ru"><surname>Расщупкина</surname><given-names>Е. В</given-names></name></name-alternatives><bio xml:lang="en"><p>Urologist, Senior Laboratory Assistant of Department of Endoscopic Urology of RMAPE of Minzdrav of Russia</p></bio><bio xml:lang="ru"><p>врач-уролог, старший лаборант кафедры эндоскопической урологии</p></bio><email>doctor-ras@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Teodorovich</surname><given-names>O. V</given-names></name><name xml:lang="ru"><surname>Теодорович</surname><given-names>О. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kochiev</surname><given-names>D. G</given-names></name><name xml:lang="ru"><surname>Кочиев</surname><given-names>Д. Г</given-names></name></name-alternatives><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Andreeva</surname><given-names>Ju. Ju</given-names></name><name xml:lang="ru"><surname>Андреева</surname><given-names>Ю. Ю</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shatohin</surname><given-names>M. N</given-names></name><name xml:lang="ru"><surname>Шатохин</surname><given-names>М. Н</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Borisenko</surname><given-names>G. G</given-names></name><name xml:lang="ru"><surname>Борисенко</surname><given-names>Г. Г</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Russian Medical Academy of Postgraduate Education of Minzdrav of Russia</institution></aff><aff><institution xml:lang="ru">ГБОУ ДПО «Российская медицинская академия последипломного образования» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Research Clinical Center of JSC «Russian Railways»</institution></aff><aff><institution xml:lang="ru">НУЗ «Научный клинический центр» ОАО РЖД</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">General Physics Institute n.a. A.M. Prokhorov of RAS</institution></aff><aff><institution xml:lang="ru">ФГБУН «Институт общей физики им. А. М. Прохорова» РАН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2015</year></pub-date><issue>3</issue><issue-title xml:lang="en">NO3 (2015)</issue-title><issue-title xml:lang="ru">№3 (2015)</issue-title><fpage>55</fpage><lpage>59</lpage><history><date date-type="received" iso-8601-date="2023-02-25"><day>25</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, ООО «Бионика Медиа»</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/1728-2985/article/view/281149">https://journals.eco-vector.com/1728-2985/article/view/281149</self-uri><abstract xml:lang="en"><p>Interstitial laser coagulation (ILC) is one of the minimally invasive and minimally traumatic methods for the destruction of small lesions in various organs and tissues. Selection of the optimal operation and exposure mode is critical for the safe use of ILC in clinical practice. The in-vivo study of ILC effects on bladder tissue was carried out in 6 rabbits weighing less than 3 kg. Macroscopic and microscopic analysis of the tissue was done directly after the ILK procedure, on days 3 and 7, 14 and 21 following specimen collection of experimental animals. Safety and efficacy of ND: YAG laser impact on bladder tissues were confirmed by morphological study, which established phasing and extent of changes in the bladder tissues. The results allow us to recommend ILC application for the destruction of small size bladder tumors without impairment of the bladder functions, as well as for the treatment of bottom after transurethral resection of bladder cancer.</p></abstract><trans-abstract xml:lang="ru"><p>Интерстициальная лазерная коагуляция (ИЛК) - один из малоинвазивных и малотравматичных эффективных методов для деструкции малых образований различных: органов и тканей. Выбор режима воздействия и методики проведения процедуры необходим для безопасного применения ИЛК в клинической практике. In vivo изучены результаты лазерного воздействия в различных режимах на ткани мочевого пузыря 6 кроликов массой не более 3 кг. Макро- и микроскопическому анализу ткани были подвергнуты непосредственно после процедуры ИЛК, на 3-и, 7, 14 и 21-е сутки после забора органа у подопытного животного. Данные морфологического исследования позволили установить этапность и объемы изменений в тканях мочевого пузыря, подтверждающие безопасность и эффективность воздействия Nd:YAG-лазера на ткани мочевого пузыря. Полученные результаты позволяют рекомендовать применение ИЛК тканей мочевого пузыря для деструкции образований мочевого пузыря, а также для обработки ложа после трансуретральной резекции мочевого пузыря по поводу рака.</p></trans-abstract><kwd-group xml:lang="en"><kwd>interstitial laser coagulation</kwd><kwd>laser technology</kwd><kwd>minimally invasive technology</kwd><kwd>renal tumors</kwd><kwd>tumors of the bladder</kwd><kwd>prostate cancer</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>интерстициальная лазерная коагуляция</kwd><kwd>лазерные технологии</kwd><kwd>малоинвазивные технологии</kwd><kwd>опухоли почек</kwd><kwd>опухоли мочевого пузыря</kwd><kwd>рак простаты</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Brausi M., Collette L., Kurth K. EORTC Genito-Urinary Tract Cancer Collaborative Group. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur. Urol. 2002;41:523-531.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Vogel A., Venugopalan V. Mechanisms of pulsed laser ablation of biological tissues. Chemical Reviews. 2003;103(2):577-644.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Niemz M.H. Laser-Tissue Interactions: Fundamentals and Applications. Berlin: Springer, 2004.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Smith N., Thomas K. Lasers for bladder tumors. New Techniques in Surgery Series. 2010;7:71-78.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Hofstetter A.G. Application of lasers in bladder cancer. Semin. Surg. Oncol. 1992;8(4):214-216.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Мажукин В.И. Ультракороткое сверхмощное лазерное воздействие на материалы: математические модели и моделирование. Материалы IV Международного научного семинара «Математические модели и моделирование в лазерно-плазменных процессах». М.: Знание, понимание, умение. 2007;3:246.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Tuan Vo-Dinh. Biomedical photonics handbook. New York: CRC Press LLC, 2003.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Stein B.S. Urologic dosimetry studies with the Nd:YAG and CO2 lasers: bladder and kidney. Lasers Surg. Med. 1986l;6(3):353-363.</mixed-citation></ref></ref-list></back></article>
